European Respiratory Review

Papers
(The H4-Index of European Respiratory Review is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health197
Interventions for the management of malignant pleural effusions: an updated network meta-analysis161
The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review159
The application of barium oesophagography in patients with suspected tracheo-oesophageal fistula: preferred or avoided?153
The role of telemonitoring in patients on home mechanical ventilation102
Non-typeableHaemophilus influenzaeairways infection: the next treatable trait in asthma?97
European Respiratory Review, list of peer reviewers 202291
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations85
A critical interpretive synthesis of the lived experiences and health and patient-reported outcomes of people living with COPD who isolated during the COVID-19 pandemic82
Selection of potential targets for stratifying congenital pulmonary airway malformation patients with molecular imaging: is MUC1 the one?82
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis66
Metabolomics and microbiome profiling as biomarkers in obstructive sleep apnoea: a comprehensive review65
Training in interventional pulmonology: the European and US perspective63
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis62
Reply to: “Nicotine or tobacco abstinence?”60
ERS/EAACI statement on adherence to international adult asthma guidelines59
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections56
Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency55
Parasitic lung diseases54
Molecular monitoring of lung allograft health: is it ready for routine clinical use?52
Positive airway pressure therapy for post-stroke sleep disordered breathing: a systematic review, meta-analysis and meta-regression51
The world of rare interstitial lung diseases50
New trends in pulmonary hypertension49
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis46
Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework45
Preclinical models of maternal asthma and progeny outcomes: a scoping review43
Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review43
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?42
Ventilatory efficiency and its clinical and prognostic value in adults with cystic fibrosis42
Peripheral blood monocyte count and outcomes in patients with interstitial lung disease: a systematic review and meta-analysis41
Ergonomics of bronchoscopy: good advice or a pain in the neck?40
Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective39
The ventilatory efficiency and its clinical and prognostic value in cardiorespiratory disorders39
Perioperative approach to precapillary pulmonary hypertension in non-cardiac non-obstetric surgery38
Exacerbations of bronchiectasis38
Eosinophils and eosinophilic immune dysfunction in health and disease37
The efficacy of immune checkpoint inhibitors in thoracic malignancies37
0.080507040023804